"10.1371_journal.pone.0039413","plos one","2012-06-22T00:00:00Z","Maija Hollm√©n; Ping Liu; Kari Kurppa; Hans Wildiers; Irene Reinvall; Thijs Vandorpe; Ann Smeets; Karen Deraedt; Tero Vahlberg; Heikki Joensuu; Daniel J Leahy; Patrick Sch√∂ffski; Klaus Elenius","Medicity Research Laboratories, Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland; Turku Doctoral Programme of Biomedical Sciences, Turku, Finland; Department of Biophysics & Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium; Department of Surgery, University Hospital Leuven, Leuven, Belgium; Department of Pathology, University Hospital Leuven, Leuven, Belgium; Department of Statistics, University of Turku, Turku, Finland; Department of Oncology, Helsinki University Hospital, Helsinki, Finland; Leuven Cancer Institute, Leuven, Belgium; Department of Oncology, Turku University Hospital, Turku, Finland","Conceived and designed the experiments: MH PL KK HW IR DL PS KE. Performed the experiments: MH PL KK IR. Analyzed the data: MH PL KK HW IR T. Vandorpe T. Vahlberg DL KE. Contributed reagents/materials/analysis tools: HW AS KD HJ PS. Wrote the paper: MH HW HJ DL PS KE.","MH and KE are inventors in a patent CA 2744512 (A1) describing the mAb 1479 antibody. This does not alter the authors‚Äô adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Maija Hollm√©n","MH√",13,TRUE,8,4,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
